当前位置：药药网 / 药品 / 美国NDC复合药物数据库文件(本栏目收费,不能显示细节,电话13136136841)
药品名称： 商品名称： 药品NDC： 报告期内： -格式:2020-5-3
NDC包装id： 市场分类： 活性成分： 持证企业：
 美国NDC复合药物数据库文件1279条(本栏目收费,不能显示细节,电话13136136841)
药品名称(分析)
商品名
药品NDC
专利人(分析)
报告期内
活性成分
市场分类
规格(分析)
NDC包装id
Testosterone/Anastrozole
HUMAN COMPOUNDED DRUG
70168-0520
BSO, LLC
2021/2/1 0:00:00
TESTOSTERONE; ANASTROZOLE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
200 mg; 8 mg
70168-0520-1
Testosterone Cypionate/Anastrozole 200/1mg/mL
HUMAN COMPOUNDED DRUG
70168-0620
BSO, LLC
2021/2/1 0:00:00
ANASTROZOLE; TESTOSTERONE CYPIONATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1 mg/1 mL; 200 mg/1 mL
70168-0620-1
Testosterone Cypionate/Anastrozole 200/0.5mg/mL
HUMAN COMPOUNDED DRUG
70168-0610
BSO, LLC
2021/2/1 0:00:00
ANASTROZOLE; TESTOSTERONE CYPIONATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.5 mg/1 mL; 200 mg/1 mL
70168-0610-1
Testosterone Cypionate/DHEA 200/10mg/mL
HUMAN COMPOUNDED DRUG
70168-0630
BSO, LLC
2021/2/1 0:00:00
PRASTERONE; TESTOSTERONE CYPIONATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 mg/1 mL; 200 mg/1 mL
70168-0630-1
Betamethasone Dipropionate/Minoxidil/Niacinamide/Pentoxifylline
HUMAN COMPOUNDED DRUG
72627-3189
Empower Pharmacy
2021/2/1 0:00:00
BETAMETHASONE DIPROPIONATE; NIACINAMIDE; MINOXIDIL; PENTOXIFYLLINE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.5 mg/1 g; 20 mg/1 g; 50 mg/1 g; 5 mg/1 g
72627-3189-8
Azelaic Acid/Ivermectin/Metronidazole/Niacinamide
HUMAN COMPOUNDED DRUG
72627-3111
Empower Pharmacy
2021/2/1 0:00:00
AZELAIC ACID; NIACINAMIDE; METRONIDAZOLE; IVERMECTIN
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
50 mg/1 g; 40 mg/1 g; 10 mg/1 g; 10 mg/1 g
72627-3111-1
Alpha Lipoic Acid/Ascorbic Acid/Azelaic Acid/Estriol/Progesterone
HUMAN COMPOUNDED DRUG
72627-3108
Empower Pharmacy
2021/2/1 0:00:00
PROGESTERONE; AZELAIC ACID; ESTRIOL; ASCORBIC ACID; ALPHA LIPOIC ACID
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
20 mg/1 g; 50 mg/1 g; 1 mg/1 g; 100 mg/1 g; 10 mg/1 g
72627-3108-1
Niacinamide/Sodium Hyaluronate/Tretinoin
HUMAN COMPOUNDED DRUG
72627-3128
Empower Pharmacy
2021/2/1 0:00:00
TRETINOIN; NIACINAMIDE; HYALURONATE SODIUM
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.5 mg/1 g; 40 mg/1 g; 5 mg/1 g
72627-3128-1
Sermorelin Acetate
HUMAN COMPOUNDED DRUG
72627-2312
Empower Pharmacy
2021/2/1 0:00:00
SERMORELIN ACETATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
2 mg/1 mL
72627-2312-1
Dapsone/Niacinamide
HUMAN COMPOUNDED DRUG
72627-3129
Empower Pharmacy
2021/2/1 0:00:00
DAPSONE; NIACINAMIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
85 mg/1 g; 40 mg/1 g
72627-3129-1
Sermorelin Acetate
HUMAN COMPOUNDED DRUG
72627-2314
Empower Pharmacy
2021/2/1 0:00:00
SERMORELIN ACETATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
2 mg/1 mL
72627-2314-1
Sermorelin Acetate
HUMAN COMPOUNDED DRUG
72627-2313
Empower Pharmacy
2021/2/1 0:00:00
SERMORELIN ACETATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
2 mg/1 mL
72627-2313-1
Azelaic Acid/Finasteride/Ketoconazole/Minoxidil
HUMAN COMPOUNDED DRUG
72627-3208
Empower Pharmacy
2021/2/1 0:00:00
AZELAIC ACID; KETOCONAZOLE; MINOXIDIL; FINASTERIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
125 mg/1 g; 20 mg/1 g; 50 mg/1 g; 1 mg/1 g
72627-3208-8
Hydrocortisone/Hydroquinone/Tretinoin
HUMAN COMPOUNDED DRUG
72627-3127
Empower Pharmacy
2021/2/1 0:00:00
HYDROCORTISONE; HYDROQUINONE; TRETINOIN
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 mg/1 g; 80 mg/1 g; 1 mg/1 g
72627-3127-1
Midazolam HCl
HUMAN COMPOUNDED DRUG
61141-1337
Medi-Fare Drug
2021/2/1 0:00:00
MIDAZOLAM
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1 mg/1 mL
61141-1337-1
Povidone-Iodine Repak
HUMAN COMPOUNDED DRUG
61141-4538
Medi-Fare Drug
2021/2/1 0:00:00
POVIDONE-IODINE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
50 mg/1 mL
61141-4538-4
Hydrocortisone/Hydroquinone/Tretinoin
HUMAN COMPOUNDED DRUG
72627-3188
Empower Pharmacy
2021/2/1 0:00:00
HYDROCORTISONE; HYDROQUINONE; TRETINOIN
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
5 mg/1 g; 40 mg/1 g; .25 mg/1 g
72627-3188-1
Hydrocortisone/Hydroquinone/Tretinoin
HUMAN COMPOUNDED DRUG
72627-3171
Empower Pharmacy
2021/2/1 0:00:00
HYDROCORTISONE; HYDROQUINONE; TRETINOIN
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
5 mg/1 g; 80 mg/1 g; .25 mg/1 g
72627-3171-1
Hydrocortisone/Hydroquinone/Tretinoin
HUMAN COMPOUNDED DRUG
72627-3210
Empower Pharmacy
2021/2/1 0:00:00
HYDROCORTISONE; HYDROQUINONE; TRETINOIN
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
5 mg/1 g; 80 mg/1 g; 1 mg/1 g
72627-3210-1
Azelaic Acid/Hydroquinone/Tretinoin
HUMAN COMPOUNDED DRUG
72627-3160
Empower Pharmacy
2021/2/1 0:00:00
AZELAIC ACID; HYDROQUINONE; TRETINOIN
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
20 mg/1 g; 60 mg/1 g; .25 mg/1 g
72627-3160-1
网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈
免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，医药网对此不承担任何责任。
相关链接：医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究　　客服热线：0575-83552251 / 13754370441  QQ客服：药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　浙公网安备:330683240604819103159
　医药代理商群１：药药网药品采购交流医药代理商群２：药药网药品采购交流2医药代理商群３：药药网药品采购交流3